GENEVA, March 31 (Reuters) - Chinese vaccine makers Sinopharm and Sinovac have presented data on their COVID-19 vaccines indicating levels of efficacy that would be compatible with those required by the World Health Organization, the chair of a WHO advisory panel said on Wednesday.
The WHO's Strategic Advisory Group of Experts (SAGE) hopes to issue recommendations on those vaccines by the end of April, its chair Alejandro Cravioto, told a news briefing.
The vaccines would first require WHO emergency use listing.
(Reporting by Stephanie Nebehay and Kate Kelland;)
Our Standards: The Thomson Reuters Trust Principles.